Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters

Clinical Hemorheology and Microcirculation

Volumn 41, Issue 4, 2009, Pages 241-249

  Tazbirek, MacIej ^a   Slowinska, Ludmila ^a   Skoczynski, Szymon ^a   Pierzchala, Wladyslaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiovascular diseases; Erythrocyte deformability; Hemorheology; Obstructive sleep apnea; Oxidative stress; Plasma viscosity

Indexed keywords

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CELL AGGREGATION; CELL DAMAGE; CELL ELONGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ERYTHROCYTE; ERYTHROCYTE AGGREGATION; HEMATOCRIT; HUMAN; MALE; OBESITY; OXIDATIVE STRESS; PLASMA VISCOSITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; BLOOD; ERYTHROCYTE DEFORMABILITY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BLOOD VISCOSITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; ERYTHROCYTE DEFORMABILITY; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 65549086567     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1175     Document Type: Article

References (26)

1. W.T. McNicholas, M.R. Bonsignore and the Management Committee of EU COST ACTION B26, Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanism and research priorities, Eur. Resp. J. 29 (2007), 156-178.
2. American Academy of Sleep Medicine (AASM), International Classification of Sleep Disorders, AASM, Westchester, 2005.
3. N. Dikmenoglu, B. Ciftci, E. Ileri, S.F. Guven, N. Seringec, Y. Aksoy and D. Ercil, Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome, Sleep-Med. 7 (2006), 255-261.
4. E. Kasasbeh, D.S. Chi and G. Krishnaswamy, Inflammatory aspects of sleep apnea and their cardiovascular consequences, South Med. J. 99 (2006), 58-67.
5. G. Kesmarky, K. Toth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin. Hemorheol. Microcirc. 18 (1998), 245-251.
6. M. Wiewiora, L. Slowinska, M. Wylezol, M. Pardela and A. Kobielski, Rheological properties of erytrocytem in patients suffering from norbid obesity. Examination with LORCA device, Clin. Hemorheol. Microcirc. 34 (2006), 499-506.
7. G.V. Robinson, J.C. Pepperell, H.C. Segal, R.J. Davies and J.R. Stradling, Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomized controlled trials, Thorax 59 (2004), 777-782.
8. S. Steiner, T. Jax, S. Evers, M. Hennersdorf, A. Schwalen and B.E. Strauer, Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk, Cardiology 104 (2005), 92-96.
9. S.M. Harding, Complications and consequences of obstructive sleep apnea, Curr. Opin. Pulm. Med. 6 (2000), 485-489.
10. K. Chin, M. Ohi, H. Kita, T. Noguchi, N. Otsuka, T. Tsuboi, M. Mishima and K. Kuno, Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome, Am. J. Respir. Crit. Care Med. 153 (1996), 1972-1976.
11. L. Nobili, G. Schiavi, E. Bozano, F. De Carli, F. Ferrillo and F. Nobili, Morning increase of whole blood viscosity in obstructive sleep apnea syndrome, Clin. Hemorheol. Microcirc. 22 (2000), 21-27.
12. W.H. Reinhart, J. Oswald, R. Walter and M. Kuhn, Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure, Clin. Hemorheol. Microcirc. 27 (2002), 201-207.
13. G.D. Lowe, Blood viscosity, lipoproteins and cardiovascular risk, Circulation 85 (1992), 2329-2331.
14. N. Maeda, I. Cicha, N. Tateishi and Y. Suzuki, Triglyceride in plasma: prospective effects on microcirculatory functions, Clin. Hemorheol. Microcirc. 34 (2006), 341-346.
15. T.E. Wessendorf, A.F. Thilmann and Y.M. Wang, Fibrinogen levels and obstructive sleep apnea in ischemic stroke, Am. J. Respir. Crit. Care Med. 162 (2000), 2039-2042.
16. A.S. Shamsuzzaman, B.J. Gersh and V.K. Somers, Obstructive sleep apnea: Implications for cardiac and vascular disease, JAMA 290 (2003), 1906-1914.
17. O. Az, O. Rogowski, I. Shapira, N. Maharshak, Y. Karni and S. Berliner, Dissociated effects of physical activity and weight loss on fibrinogen concentrations and markers of red blood cell aggregation. Relevance for life style modification in atherothrombosis, Clin. Hemorheol. Microcirc. 37 (2007), 253-262.
18. R. Plasenzotti, U. Windberger, F. Ulberth, W. Osterode and U. Losert, Influence of fatty acid composition in mammalian erythrocytes on cellular aggregation, Clin. Hemorheol. Microcirc. 37 (2007), 237-243.
19. K. Keddad, S.M. Razavian, C. Baussan, J. Chalas, A. Abella, J. Levenson, A. Simon, N. Moatti and A. Legrand, Blood lipids and rheological modifications in glycogen storage disease, Clin. Biochem. 29 (1996), 73-78.
20. D. Zilberman-Kravits, I. Harman-Boehm, T. Shuster and N. Meyerstein, Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes, Clin. Hemorheol. Microcirc. 35 (2006), 463-471.
21. I. Cicha, Y. Suzuki, N. Tateishi and N. Maeda, Enhancement of red blood cell aggregation by plasma triglycerides, Clin. Hemorheol. Microcirc. 24 (2001), 247-255.
22. G. Cicco and A. Pirrelli, Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension, Clin. Hemorheol. Microcir. 21 (1999), 169-177.
23. S.B. Shohet and S.E. Bicknese, Defining the architecture of the red blood cell membrane: newer biophysical approaches, Am. J. Hematol. 42 (1993), 19-24.
24. H. Landgraf, Correlation between plasma viscosity and tissue oxygen tension, Clin. Hemorheol. Microcirc. 20 (1999), 37-40.
25. R.T. Dean and I. Wilcox, Possible atherogenic effects of hypoxia during obstructive sleep apnea, Sleep 16 (1993), 15-22.
26. I. Aloulou, E. Varlet-Marie, J. Mercier and J.F. Brun, Hemorheologic effects of low intensity endurance training in sedentary patients suffering from the metabolic syndrome, Clin. Hemorheol. Microcirc. 35 (2006), 333-339.